Elanco Animal Health Incorporated
ELAN
주식 순위
#1871
Elanco Animal Health, a firm dedicated to animal well-being, creates, produces,... Elanco Animal Health, a firm dedicated to animal well-being, creates, produces, and commercializes a diverse array of solutions for both companion animals and livestock. For household pets, the company provides preventative health solutions, including parasiticides and vaccinations, designed to guard against common ailments like worms, fleas, and ticks, with notable brands such as Seresto, Advantage, Advantix, and Advocate. Additionally, Elanco supplies therapeutic treatments for canine and feline conditions including pain, osteoarthritis, ear infections, cardiovascular issues, and dermatological problems, marketed under labels like Galliprant and Claro. Its portfolio for agricultural animals encompasses vaccines, antibiotics, parasiticides, and other essential products for poultry and aquaculture farming. This segment also features nutritional supplements such as enzymes, probiotics, and prebiotics to support animal health and growth. Furthermore, the company offers a comprehensive suite of products for ruminant and swine operations, comprising vaccines, antibiotics, implants, and parasiticides, often recognized by brands like Rumensin and Baytril. Elanco distributes its offerings through various channels, including independent distributors, veterinary clinics, and a broad spectrum of farm animal producers, from cattle and dairy farms to pig, poultry, and aquaculture enterprises. Established in 1954, Elanco Animal Health Incorporated maintains its corporate headquarters in Greenfield, Indiana.
주가
$22.70
시가총액
$11.34B
변동 (1일)
-3.45%
변동 (1년)
4.49%
국가
US
거래 Elanco Animal Health Incorporated (ELAN)
카테고리
Healthcare
Elanco Animal Health Incorporated (ELAN)의 P/B 비율
October 2026 기준 P/B 비율 TTM: 1.71
Elanco Animal Health Incorporated의 최신 재무 보고서와 주가에 따르면 현재 P/B 비율(TTM)은 1.71입니다. 2023년 말 기준 P/B 비율은 1.18였습니다.
Elanco Animal Health Incorporated의 P/B 비율 기록 (2015 ~ 2026)
매년 말 P/B 비율
| 연도 | P/B 비율 | 변화 |
|---|---|---|
| 2026 (TTM) | 1.71 | 74.46% |
| 2024 | 0.98 | -16.74% |
| 2023 | 1.18 | 43.99% |
| 2022 | 0.82 | -55.37% |
| 2021 | 1.83 | 14.84% |
| 2020 | 1.60 | -18.47% |
| 2019 | 1.96 | 2.95% |
| 2018 | 1.90 | 15.62% |
| 2017 | 1.65 | -9.79% |
| 2016 | 1.82 | 0.00% |
| 2015 | 0.00 | 0.00% |
유사 기업 또는 경쟁사의 P/B 비율
| 회사 | P/B 비율 | P/B 비율 차이 | 국가 |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 5.041 | 194.85% |
IN
|
